Compliance: 8 tips to protect your practice, patients from opioid Rx abuse

Why This Topic Matters

Opioid prescribing remains a high-risk compliance area for medical practices because failures can trigger regulatory, legal, and licensure consequences. Understanding the article helps readers evaluate whether their prescribing policies, monitoring processes, and relationships with outside entities may need review.

Article Sections

1. Compliance risks tied to opioid prescribing

   Introduces the regulatory and legal exposure associated with opioid prescribing and describes the general compliance environment surrounding this topic.

2. Prescribing cautiously

   Discusses a conservative approach to opioid prescribing and the importance of limiting exposure when treating pain.

3. Guidelines, protocols, and monitoring practices

   Covers the use of external guidance, treatment planning, and monitoring processes used in long-term opioid therapy.

4. Reviewing prescribing habits and patient behavior

   Addresses internal review of prescribing patterns and broader concerns about identifying misuse or diversion risk.

5. Prescription drug monitoring programs

   Explains the role of state database checks in understanding a patient’s prescription history and potential misuse concerns.

6. Pharmacy relationships and legal scrutiny

   Summarizes concerns about relationships between prescribers and pharmacies and the general legal issues those relationships can raise.

7. State law and office dispensing considerations

   Highlights evolving state requirements and office-based handling of controlled substances, including heightened oversight issues.